[HTML][HTML] Challenges and solutions for the benefit assessment of tumor-agnostic therapies in Germany
J Schiller, H Eckhardt, S Schmitter, VA Alber, T Rombey - Value in Health, 2023 - Elsevier
Objectives Precision medicine is increasingly important in cancer treatment. Tumor-agnostic
therapies are used regardless of tumor entity because they target specific biomarkers in …
therapies are used regardless of tumor entity because they target specific biomarkers in …